These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1995089)
1. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Kelly AB; Marzec UM; Krupski W; Bass A; Cadroy Y; Hanson SR; Harker LA Blood; 1991 Mar; 77(5):1006-12. PubMed ID: 1995089 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Kelly AB; Maraganore JM; Bourdon P; Hanson SR; Harker LA Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6040-4. PubMed ID: 1385867 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons. Cadroy Y; Maraganore JM; Hanson SR; Harker LA Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1177-81. PubMed ID: 1996320 [TBL] [Abstract][Full Text] [Related]
4. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis. Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. Bode C; Hanson SR; Schmedtje JF; Haber E; Mehwald P; Kelly AB; Harker LA; Runge MS Circulation; 1997 Feb; 95(4):800-4. PubMed ID: 9054733 [TBL] [Abstract][Full Text] [Related]
7. Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates. Cadroy Y; Hanson SR; Harker LA Arterioscler Thromb; 1993 Aug; 13(8):1213-7. PubMed ID: 8343496 [TBL] [Abstract][Full Text] [Related]
8. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin. Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336 [TBL] [Abstract][Full Text] [Related]
9. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition. Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274 [TBL] [Abstract][Full Text] [Related]
10. A four-hour infusion of recombinant hirudin results in long-term inhibition of arterial-type thrombosis in baboons. Kotzé HF; Lamprecht S; Badenhorst PN Blood; 1995 Jun; 85(11):3158-63. PubMed ID: 7756648 [TBL] [Abstract][Full Text] [Related]
11. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons. Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. Cadroy Y; Harker LA; Hanson SR J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Gruber A; Harker LA; Hanson SR; Kelly AB; Griffin JH Circulation; 1991 Dec; 84(6):2454-62. PubMed ID: 1835678 [TBL] [Abstract][Full Text] [Related]
14. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone. Hanson SR; Harker LA Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867 [TBL] [Abstract][Full Text] [Related]
15. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Meyer BJ; Fernández-Ortiz A; Mailhac A; Falk E; Badimon L; Michael AD; Chesebro JH; Fuster V; Badimon JJ Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205 [TBL] [Abstract][Full Text] [Related]
16. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin. Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009 [TBL] [Abstract][Full Text] [Related]
17. Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Harker LA; Kelly AB; Hanson SR; Krupski W; Bass A; Osterud B; FitzGerald GA; Goodnight SH; Connor WE Circulation; 1993 Mar; 87(3):1017-29. PubMed ID: 8443878 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. Hanson SR; Griffin JH; Harker LA; Kelly AB; Esmon CT; Gruber A J Clin Invest; 1993 Oct; 92(4):2003-12. PubMed ID: 8408654 [TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Yokoyama T; Kelly AB; Marzec UM; Hanson SR; Kunitada S; Harker LA Circulation; 1995 Aug; 92(3):485-91. PubMed ID: 7634464 [TBL] [Abstract][Full Text] [Related]
20. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis. Heras M; Chesebro JH; Webster MW; Mruk JS; Grill DE; Penny WJ; Bowie EJ; Badimon L; Fuster V Circulation; 1990 Oct; 82(4):1476-84. PubMed ID: 2401076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]